Search research articles
Contact Us
Filters
Showing results (41-50 of 92) with videos related to
Page
of 10
Sort By:
JACC. Cardiovascular Interventions
|
May 21, 2021
Assessment of 5-Year Mortality Outcomes for Femoropoliteal Interventions Using Drug-Eluting Devices in the REAL-PTX Study
Tim Wittig, Thomas Zeller, Marc Bosiers, et al.
Trials
|
February 21, 2014
IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial
Thomas Zeller, Iris Baumgartner, Dierk Scheinert, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
March 30, 2017
One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia
Marc Bosiers, Joren Callaert, Koen Keirse, et al.
The Journal of Cardiovascular Surgery
|
May 27, 2017
BeGraft Peripheral PMCF Study: 12-month results
Koen Deloose, Marc Bosiers, Joren Callaert, et al.
The Journal of Cardiovascular Surgery
|
July 12, 2019
Improvements in patient outcomes with next generation endovascular aortic repair devices in the ENGAGE Global Registry and the EVAR-1 clinical trial
Dittmar Böckler, Adam H Power, Lee H Bouwman, et al.
JACC. Cardiovascular Interventions
|
October 24, 2015
Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries)
Thomas Zeller, Ulrich Beschorner, Ernst Pilger, et al.
The Journal of Cardiovascular Surgery
|
April 18, 2019
One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients
Kim Taeymans, Marc Bosiers, Koen Deloose, et al.
Journal of the American College of Cardiology
|
February 16, 2019
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease
Yvonne Bausback, Tim Wittig, Andrej Schmidt, et al.
Journal of Vascular Surgery
|
December 16, 2011
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease
Marc Bosiers, Dierk Scheinert, Patrick Peeters, et al.
Journal of Vascular Surgery
|
May 7, 2013
The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II)
Jon S Matsumura, Dai Yamanouchi, Jeffrey A Goldstein, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 92) with videos related to
Sort By:
Page
of 10
JACC. Cardiovascular Interventions
|
May 21, 2021
Assessment of 5-Year Mortality Outcomes for Femoropoliteal Interventions Using Drug-Eluting Devices in the REAL-PTX Study
Tim Wittig, Thomas Zeller, Marc Bosiers, et al.
Trials
|
February 21, 2014
IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial
Thomas Zeller, Iris Baumgartner, Dierk Scheinert, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
March 30, 2017
One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia
Marc Bosiers, Joren Callaert, Koen Keirse, et al.
The Journal of Cardiovascular Surgery
|
May 27, 2017
BeGraft Peripheral PMCF Study: 12-month results
Koen Deloose, Marc Bosiers, Joren Callaert, et al.
The Journal of Cardiovascular Surgery
|
July 12, 2019
Improvements in patient outcomes with next generation endovascular aortic repair devices in the ENGAGE Global Registry and the EVAR-1 clinical trial
Dittmar Böckler, Adam H Power, Lee H Bouwman, et al.
JACC. Cardiovascular Interventions
|
October 24, 2015
Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries)
Thomas Zeller, Ulrich Beschorner, Ernst Pilger, et al.
The Journal of Cardiovascular Surgery
|
April 18, 2019
One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients
Kim Taeymans, Marc Bosiers, Koen Deloose, et al.
Journal of the American College of Cardiology
|
February 16, 2019
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease
Yvonne Bausback, Tim Wittig, Andrej Schmidt, et al.
Journal of Vascular Surgery
|
December 16, 2011
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease
Marc Bosiers, Dierk Scheinert, Patrick Peeters, et al.
Journal of Vascular Surgery
|
May 7, 2013
The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II)
Jon S Matsumura, Dai Yamanouchi, Jeffrey A Goldstein, et al.
Page
of 10